Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L34 pseudogene 27 is a processed non-coding pseudogene related to the ribosomal protein L34 gene (RPL34). Pseudogenes like RPL34P27 are typically nonfunctional remnants of protein-coding genes and do not produce functional proteins. Unlike its parental gene RPL34, which encodes a component of the large 60S subunit of ribosomes essential for protein synthesis and is implicated in cancer biology, RPL34P27 has no documented biological activity, function as a therapeutic target, or disease-modifying role[1][2][6][8]. Its significance, if any, might lie in genomic studies or the regulation of its related coding gene, but this is not well established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L34 pseudogene 27 (RPL34P27).